Literature DB >> 33467724

Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.

Iwona Karwaciak1, Anna Sałkowska2, Kaja Karaś2, Jarosław Dastych3, Marcin Ratajewski2.   

Abstract

The pandemic of the new coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has led to the deaths of more than 1.5 million people worldwide. SARS-CoV-2 causes COVID-19, which exhibits wide variation in the course of disease in different people, ranging from asymptomatic and mild courses to very severe courses that can result in respiratory failure and death. Despite the rapid progression of knowledge, we still do not know how individual cells of the immune system interact with the virus or its components, or how immune homeostasis becomes disrupted, leading to the rapid deterioration of a patient's condition. In the present work, we show that SARS-CoV-2 proteins induce the expression and secretion of IL-6 by human monocytes and macrophages, the first line cells of antiviral immune responses. IL-6 may play a negative role in the course of COVID-19 by inhibiting Th1-dependent immunity and stimulating Th17 lymphocytes, thus leading to an increased probability of a cytokine storm.

Entities:  

Keywords:  COVID-19; IL-6; SARS-COV-2; cytokine storm; macrophages; monocytes

Year:  2021        PMID: 33467724      PMCID: PMC7830532          DOI: 10.3390/vaccines9010054

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  50 in total

1.  Differentiation stage-specific effect of histone deacetylase inhibitors on the expression of RORγT in human lymphocytes.

Authors:  Anna Sałkowska; Kaja Karaś; Aurelia Walczak-Drzewiecka; Jarosław Dastych; Marcin Ratajewski
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

2.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.

Authors:  Yong Jiang; Jun Xu; Chengzhi Zhou; Zhenguo Wu; Shuqing Zhong; Jinghua Liu; Wei Luo; Tao Chen; Qinghe Qin; Peng Deng
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

3.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells.

Authors:  Tomoki Yoshikawa; Terence Hill; Kui Li; Clarence J Peters; Chien-Te K Tseng
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

5.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro.

Authors:  Susan F Dosch; Supriya D Mahajan; Arlene R Collins
Journal:  Virus Res       Date:  2009-01-29       Impact factor: 3.303

7.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

8.  Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection.

Authors:  Christian Drosten; Michael Seilmaier; Victor M Corman; Wulf Hartmann; Gregor Scheible; Stefan Sack; Wolfgang Guggemos; Rene Kallies; Doreen Muth; Sandra Junglen; Marcel A Müller; Walter Haas; Hana Guberina; Tim Röhnisch; Monika Schmid-Wendtner; Souhaib Aldabbagh; Ulf Dittmer; Hermann Gold; Petra Graf; Frank Bonin; Andrew Rambaut; Clemens-Martin Wendtner
Journal:  Lancet Infect Dis       Date:  2013-06-17       Impact factor: 25.071

Review 9.  Epidemiological analysis of COVID-19 and practical experience from China.

Authors:  Qing Ye; Bili Wang; Jianhua Mao; Junfen Fu; Shiqiang Shang; Qiang Shu; Ting Zhang
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 20.693

View more
  16 in total

1.  Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Li Tao; Meyer Gershater; Yaozhu Leng; Chengrui Zou; Marcelo Farias-Jofre; Jose Galaz; Derek Miller; Adi L Tarca; Marcia Arenas-Hernandez; Gaurav Bhatti; Valeria Garcia-Flores; Zhenjie Liu; Robert Para; Tomi Kanninen; Ola Hadaya; Carmen Paredes; Yi Xu
Journal:  J Immunol       Date:  2022-04-04       Impact factor: 5.426

2.  Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection.

Authors:  Santhamani Ramasamy; Afsal Kolloli; Ranjeet Kumar; Seema Husain; Patricia Soteropoulos; Theresa L Chang; Selvakumar Subbian
Journal:  Biomedicines       Date:  2022-06-07

3.  Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes.

Authors:  Iwona Karwaciak; Kaja Karaś; Anna Sałkowska; Joanna Pastwińska; Marcin Ratajewski
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

4.  Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.

Authors:  Matteo Stravalaci; Isabel Pagani; Elvezia Maria Paraboschi; Mattia Pedotti; Andrea Doni; Francesco Scavello; Sarah N Mapelli; Marina Sironi; Chiara Perucchini; Luca Varani; Milos Matkovic; Andrea Cavalli; Daniela Cesana; Pierangela Gallina; Nicoletta Pedemonte; Valeria Capurro; Nicola Clementi; Nicasio Mancini; Pietro Invernizzi; Rafael Bayarri-Olmos; Peter Garred; Rino Rappuoli; Stefano Duga; Barbara Bottazzi; Mariagrazia Uguccioni; Rosanna Asselta; Elisa Vicenzi; Alberto Mantovani; Cecilia Garlanda
Journal:  Nat Immunol       Date:  2022-01-31       Impact factor: 31.250

Review 5.  Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19.

Authors:  Gergana Taneva; Dimitar Dimitrov; Tsvetelina Velikova
Journal:  World J Hepatol       Date:  2021-12-27

6.  Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1.

Authors:  Theodore J Cory; Russell S Emmons; Johnathan R Yarbro; Kierstin L Davis; Brandt D Pence
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

7.  The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production.

Authors:  Jun Shimizu; Tadahiro Sasaki; Atsushi Yamanaka; Yoko Ichihara; Ritsuko Koketsu; Yoshihiro Samune; Pedro Cruz; Kei Sato; Naomi Tanga; Yuka Yoshimura; Ami Murakami; Misuzu Yamada; Kiyoe Itoi; Emi E Nakayama; Kazuo Miyazaki; Tatsuo Shioda
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

8.  Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19.

Authors:  Davoud Ghazanfari; Maria Cecilia Courreges; Lydia Belinski; Stephen C Bergmeier; Kelly D McCall; Douglas J Goetz
Journal:  Biochem Biophys Res Commun       Date:  2022-03-16       Impact factor: 3.575

9.  In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release.

Authors:  Maria Dolci; Lucia Signorini; Sarah D'Alessandro; Federica Perego; Silvia Parapini; Michele Sommariva; Donatella Taramelli; Pasquale Ferrante; Nicoletta Basilico; Serena Delbue
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

10.  Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology.

Authors:  Amelia Barilli; Rossana Visigalli; Francesca Ferrari; Massimiliano G Bianchi; Valeria Dall'Asta; Bianca Maria Rotoli
Journal:  Biomedicines       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.